- Organizations: Nordic Pharmra
Research
TFOS DEWS III report includes use of Lacrifill canalicular gel
Latest installment details two clinical studies validating the use of Nordic Pharma’s FDA-cleared, patented dry eye therapy device.
Products
Nordic Pharma launches authorized generic of Maxitrol
Company to introduce prescription-based drop in partnership with Harrow; indication includes treating and relieving bacterial eye infections.
Products
Nordic Pharma launches Lacrifill Canalicular Gel dry eye therapy in the US
Novel patented device temporarily blocks tear drainage to maximize tear film preservation in dry eye patients.
Business
Amring Pharmaceuticals is now Nordic Pharma
Company cites recent ophthalmic product acquisitions in quest to focus exclusively on eye care.
Business
Eric Donnenfeld, MD, joins Nordic Group as chair of Medical Advisory Board
Appointment coincides with preparations for launch of LACRIFILL, a cross-linked hyaluronic acid-based canalicular occlusive device for DED.
Business
Amring names new COO, forms US Medical Advisory Board
Nordic Pharma’s subsidiary appoints Jai G. Parekh, MD, MBA, FAAO, to its US team.
Business